NASDAQ Companies

LOS ALTOS, Calif., April 10, 2024 (GLOBE NEWSWIRE) — Unicycive Therapeutics, Inc. (Nasdaq: UNCY), a clinical-stage biotechnology company developing therapies for […]

MALVERN, Pa., April 10, 2024 (GLOBE NEWSWIRE) — Ocugen, Inc. (“Ocugen” or the “Company”) (NASDAQ: OCGN), a biotechnology company focused […]

HOOKIPA announces alignment with FDA on pivotal trial design and protocol for HB-200 in combination with pembrolizumab HB-200 program receives […]

TORONTO and PHILADELPHIA, April 10, 2024 (GLOBE NEWSWIRE) — Leading diversified professional services and investment management firm Colliers (NASDAQ and […]

Singapore, April 10, 2024 (GLOBE NEWSWIRE) — Nova Vision Acquisition Corp. (NASDAQ: NOVV, the “Company”), a special purpose acquisition company, […]

Extended the Strategic Collaboration with Gilead Sciences Extended the Strategic Collaboration with Sanofi to Develop Novel Orally Available Targeted Protein […]

NEW YORK, April 10, 2024 (GLOBE NEWSWIRE) — Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company developing and delivering novel […]

DODGEVILLE, Wis., April 10, 2024 (GLOBE NEWSWIRE) — Lands’ End, the classic American lifestyle brand, today announced the launch of […]

Following significant strides made in advancing its late-stage pipeline with dual positive readouts in 2023 and a few more anticipated […]

Sales Highlights: Global FYTD Mar 2024 AUD$3.6 million up 154% on (prior comparative period) pcp Mar 2024 Quarter AUD$1.3 million […]